{"id":"https://openalex.org/W3083300596","doi":"https://doi.org/10.1158/1538-7445.am2020-2925","title":"Abstract 2925: Safety and efficacy of EZH2 and BRD4 dual targeting in EZH2Y641mut germinal centre-derived lymphoma","display_name":"Abstract 2925: Safety and efficacy of EZH2 and BRD4 dual targeting in EZH2Y641mut germinal centre-derived lymphoma","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083300596","doi":"https://doi.org/10.1158/1538-7445.am2020-2925","mag":"3083300596"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-2925","doi":"https://doi.org/10.1158/1538-7445.am2020-2925","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-2925","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046971336","display_name":"Ar\u00e1nzazu Chamorro-Jorganes","orcid":"https://orcid.org/0000-0002-3505-7221","observed_orcids":["https://orcid.org/0000-0002-3505-7221"]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Aranzazu Chamorro-Jorganes","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043592425","display_name":"Marcelo Lima Ribeiro","orcid":"https://orcid.org/0000-0003-4529-7832","observed_orcids":["https://orcid.org/0000-0003-4529-7832"]},"institutions":[{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marcelo L. Ribeiro","raw_affiliation_strings":["2Josep Carreras Leukaemia Research Institute, Badalona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Josep Carreras Leukaemia Research Institute, Badalona, Spain;","institution_ids":["https://openalex.org/I4210089592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006004570","display_name":"N\u00faria Profit\u00f3s-Pelej\u00e0","orcid":"https://orcid.org/0000-0001-8923-6025","observed_orcids":["https://orcid.org/0000-0001-8923-6025"]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nuria Profitos-Peleja","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012806375","display_name":"Diana Reyes-Garau","orcid":"https://orcid.org/0000-0002-9746-6485","observed_orcids":["https://orcid.org/0000-0002-9746-6485"]},"institutions":[{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Diana Reyes-Garau","raw_affiliation_strings":["2Josep Carreras Leukaemia Research Institute, Badalona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Josep Carreras Leukaemia Research Institute, Badalona, Spain;","institution_ids":["https://openalex.org/I4210089592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073548548","display_name":"Clara Recasens-Zorzo","orcid":"https://orcid.org/0000-0002-5039-3274","observed_orcids":["https://orcid.org/0000-0002-5039-3274"]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Clara Recasens-Zorzo","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003059028","display_name":"Juan Garc\u00eda Valero","orcid":"https://orcid.org/0000-0003-3193-9099","observed_orcids":["https://orcid.org/0000-0003-3193-9099"]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan G. Valero","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010730760","display_name":"Marc Armengol","orcid":"https://orcid.org/0000-0001-5206-9139","observed_orcids":["https://orcid.org/0000-0001-5206-9139"]},"institutions":[{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marc Armengol","raw_affiliation_strings":["2Josep Carreras Leukaemia Research Institute, Badalona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Josep Carreras Leukaemia Research Institute, Badalona, Spain;","institution_ids":["https://openalex.org/I4210089592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088316820","display_name":"P. Perez-Galan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Patricia Perez-Galan","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102319602","display_name":"Ray Butler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ray Butler","raw_affiliation_strings":["3Butler Scientifics, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Butler Scientifics, Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036114839","display_name":"Antonio A. Postigo","orcid":"https://orcid.org/0000-0003-4605-2634","observed_orcids":["https://orcid.org/0000-0003-4605-2634"]},"institutions":[{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Postigo","raw_affiliation_strings":["1IDIBAPS, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1IDIBAPS, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054008156","display_name":"Francesc Bosch","orcid":"https://orcid.org/0000-0001-9241-2886","observed_orcids":["https://orcid.org/0000-0001-9241-2886"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francesc Bosch","raw_affiliation_strings":["4Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038937943","display_name":"Ga\u00ebl Rou\u00e9","orcid":"https://orcid.org/0000-0003-0245-2257","observed_orcids":["https://orcid.org/0000-0003-0245-2257"]},"institutions":[{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gael Roue","raw_affiliation_strings":["2Josep Carreras Leukaemia Research Institute, Badalona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Josep Carreras Leukaemia Research Institute, Badalona, Spain;","institution_ids":["https://openalex.org/I4210089592"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"2925","last_page":"2925"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8568999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8568999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.04659999907016754,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.7609999775886536},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.8320000171661377},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bet-bromodomain-inhibition","display_name":"BET bromodomain inhibition","score":0.7509999871253967},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.593999981880188},{"id":"https://openalex.org/keywords/h3k27me3","display_name":"H3K27me3","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9490000009536743},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.7648895978927612},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6587749719619751},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5539365410804749},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4769631624221802},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45563948154449463},{"id":"https://openalex.org/C2777537477","wikidata":"https://www.wikidata.org/wiki/Q17847411","display_name":"BCL6","level":5,"score":0.4382556974887848},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.25298696756362915},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.24266067147254944},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.20748528838157654},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20249757170677185},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1131049394607544},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11295497417449951},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-2925","doi":"https://doi.org/10.1158/1538-7445.am2020-2925","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-2925","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2803775493","https://openalex.org/W3004400585","https://openalex.org/W2751433983","https://openalex.org/W2342623802","https://openalex.org/W2085276059","https://openalex.org/W4309739706","https://openalex.org/W1844082354","https://openalex.org/W2175416579","https://openalex.org/W3208860784","https://openalex.org/W2179439382"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"significant":[2,319],"proportion":[3],"of":[4,22,34,68,70,90,124,158,192,201,211,253,264,298,311,348,352,386,400,404],"diffuse":[5],"large":[6],"B":[7,300],"cell":[8,113,189,217],"lymphoma":[9,13,396],"(DLBCL)":[10],"and":[11,31,66,80,92,102,111,135,150,187,221,224,245,280,291,295,321,329,332,338,384,388,415],"follicular":[12],"(FL)":[14],"patients":[15],"harbor":[16],"a":[17,154,172,237,283,349],"gain-of-function,":[18],"heterozygous":[19],"somatic":[20],"mutations":[21],"the":[23,64,71,230,288,296,309,346,401,405],"methyltransferase":[24,198],"gene":[25,130,212,290],"EZH2.":[26],"Despite":[27],"acceptable":[28],"safety":[29,322],"profile":[30],"early":[32],"signs":[33],"activity":[35,65,101,126,240,320],"in":[36,50,81,106,108,148,151,181,241,246,267,308,326,336,339,392],"clinical":[37],"trials,":[38],"single":[39,78,166,324],"agent":[40,79,167,325],"treatment":[41,170,206],"with":[42,83,94,171,209,229,269,341],"EZH2":[43,72,96,193,242,327,387],"inhibitors":[44],"is":[45],"unlikely":[46],"to":[47,56,164,215],"be":[48],"curative":[49],"aggressive":[51],"lymphomas.":[52],"In":[53,315],"an":[54],"effort":[55],"established":[57],"novel":[58],"rational":[59],"combinations,":[60],"we":[61],"have":[62],"evaluated":[63],"mechanism":[67],"action":[69],"small":[73],"molecule":[74],"inhibitor":[75,234],"CPI169":[76,99,165,176,205,317],"as":[77,304,323],"combination":[82,169,228],"BET":[84,233],"bromodomain":[85],"inhibition,":[86,343],"using":[87,153],"preclinical":[88],"models":[89],"DLBCL":[91,110,186,250],"FL":[93,112,188,330],"distinct":[95],"mutational":[97],"status.":[98],"anti-tumor":[100],"specificity":[103],"was":[104,146,207,256],"assessed":[105],"vitro":[107,149,337],"10":[109],"lines,":[114,190],"including":[115],"cells":[116],"expressing":[117],"basal":[118,197],"or":[119,196],"ectopic":[120],"EZH2mut.":[121],"Molecular":[122],"bases":[123],"its":[125],"were":[127],"determined":[128],"by":[129,139,258,275,282,345],"expression":[131,194],"profiling":[132],"(GEP),":[133],"qPCR":[134],"western":[136],"blot,":[137],"followed":[138,274],"automated":[140,276],"exploratory":[141,277],"data":[142,278],"analysis.":[143],"Biomarkers":[144],"validation":[145,281],"made":[147],"vivo,":[152],"mouse":[155],"xenotransplant":[156],"model":[157],"EZH2mut":[159,249],"DLBCL,":[160],"considering":[161],"both":[162],"exposure":[163],"and/or":[168],"BRD4":[173,342,389],"inhibitor,":[174],"CPI203.":[175],"induced":[177],"dose-dependent":[178],"proliferation":[179],"blockade":[180],"EZH2mut,":[182],"but":[183],"not":[184],"EZH2wt":[185],"independently":[191],"level":[195],"activity.":[199],"Loss":[200],"H3K27me3":[202,265],"mark":[203],"upon":[204],"associated":[208],"upregulation":[210],"sets":[213],"related":[214],"G1":[216],"cycle":[218],"blockade,":[219],"mTOR":[220],"P53":[222],"pathways,":[223],"MYC":[225,270],"signaling.":[226],"Accordingly,":[227],"MYC-interfering":[231],"drug,":[232],"CPI203,":[235],"achieved":[236],"synergistic":[238,334],"anti-proliferating":[239],"mutated":[243],"cases":[244,331],"mice":[247],"bearing":[248],"tumors.":[251],"Activity":[252],"EZHi/BRD4i":[254],"combo":[255],"characterized":[257],"lower":[259],"mitotic":[260],"index,":[261],"increased":[262],"loss":[263],"mark,":[266],"association":[268],"downregulation.":[271],"GEP":[272],"analysis,":[273],"analysis":[279],"siRNA":[284],"screening,":[285],"further":[286],"identified":[287],"PI3K/AKT-regulated":[289],"mitosis":[292],"regulator,":[293],"YPEL2,":[294],"regulator":[297],"innate-like":[299],"lymphocyte":[301],"maturation,":[302],"KLHL14,":[303],"crucial":[305],"factors":[306],"involved":[307],"efficacy":[310,385],"MYC/EZH2":[312],"dual":[313,390],"targeting.":[314],"conclusion,":[316],"shows":[318],"mutated-DLBCL":[328],"displays":[333],"interaction":[335],"vivo":[340],"mediated":[344],"modulation":[347],"limited":[350],"set":[351],"EZH2-regulated":[353],"genes.":[354],"Citation":[355],"Format:":[356],"Aranzazu":[357],"Chamorro-Jorganes,":[358],"Marcelo":[359],"L.":[360],"Ribeiro,":[361],"Nuria":[362],"Profitos-Peleja,":[363],"Diana":[364],"Reyes-Garau,":[365],"Clara":[366],"Recasens-Zorzo,":[367],"Juan":[368],"G.":[369],"Valero,":[370],"Marc":[371],"Armengol,":[372],"Patricia":[373],"Perez-Galan,":[374],"Ray":[375],"Butler,":[376],"Antonio":[377],"Postigo,":[378],"Francesc":[379],"Bosch,":[380],"Gael":[381],"Roue.":[382],"Safety":[383],"targeting":[391],"EZH2Y641mut":[393],"germinal":[394],"centre-derived":[395],"[abstract].":[397],"In:":[398],"Proceedings":[399],"Annual":[402],"Meeting":[403],"American":[406],"Association":[407],"for":[408],"Cancer":[409,421],"Research":[410],"2020;":[411],"2020":[412],"Apr":[413],"27-28":[414],"Jun":[416],"22-24.":[417],"Philadelphia":[418],"(PA):":[419],"AACR;":[420],"Res":[422],"2020;80(16":[423],"Suppl):Abstract":[424],"nr":[425],"2925.":[426]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}